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Abstract
Background: The diuretic effect of valproates and its relation to urinary potassium (K+) and
chloride (Cl-) excretion have not yet been investigated, so the aim of this study was to evaluate the
influence of a single dose of sodium valproate (NaVPA) on 24-h urinary K+ and Cl- excretion in
young adult Wistar rats of both genders. For measurement of K+ in urine, the same animals and
samples as in our earlier publication were used (Pharmacology 2005 Nov, 75:111–115). The
authors propose a new approach to the pathophysiological mechanisms of NaVPA effect on K+ and
Cl- metabolism.
Twenty six Wistar rats were examined after a single intragastric administration of 300 mg/kg
NaVPA (13 NaVPA-male and 13 NaVPA-female), 28 control intact Wistar rats (14 males and 14
females) were studied as a control group. The 24-h urinary K+, Cl-, creatinine and pH levels were
measured.
Results: Total 24-h diuresis and 24-h diuresis per 100 g of body weight were found to be
significantly higher in NaVPA-rats of both genders than in rats of the control group (p < 0.05). The
data showed NaVPA to enhance 24-h K+ excretion in NaVPA-males and NaVPA-females with
significant gender-related differences: 24-h K+ excretion in NaVPA-male rats was significantly higher
than in control males (p = 0.003) and NaVPA-female rats (p < 0.001). Regarding the 24-h K+
excretion, NaVPA-female rats did not show a statistically significant difference versus females of
the control group (p > 0.05). 24-h urinary K+ excretion per 100 g of body weight in NaVPA-male
rats was significantly higher than in control males (p = 0.025). NaVPA enhanced Cl- urinary
excretion: 24-h Cl- urinary excretion, 24-h urinary Cl- excretion per 100 g of body weight and the
Cl-/creatinine ratio were significantly higher in NaVPA-male and NaVPA-female rats than in gender-
matched controls (p < 0.05). 24-h chloriduretic response to NaVPA in male rats was significantly
higher than in female rats (p < 0.05).
Conclusion: NaVPA causes kaliuretic and chloriduretic effects with gender-related differences in
rats. Further investigations are necessary to elucidate the mechanism of such pharmacological
effects of NaVPA.
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Background
Currently there are experimental data that valproate
(branched-chain fatty acid, valproic acid) increases the
turnover of γ-aminobutyric acid (GABA) and thereby
potentiates GABAergic functions [1]. The specificity of val-
proate for GABA suggests that this interaction may be an
important mechanism through which sodium valproate
(NaVPA) exerts its pharmacological effects [2]. Recently
NaVPA has shown to enhance the urinary excretion of
sodium (Na+) and chloride (Cl-) ions in both genders, but
the 24-h chloriduretic response in male rats to NaVPA was
significantly higher than in female rats [3]. The effect of
NaVPA on potassium ion (K+) excretion was not yet stud-
ied.
The aim of the present study was to evaluate the effect of
NaVPA on urininary K+ and Cl- excretion in Wistar rats of
both genders and to discuss the NaVPA effects on K+ and
Cl- metabolism that could be related to NaVPA pharmaco-
logical properties.
The GABA type A receptor (GABA(A)) is an ionotropic
receptor. Its subunits form a functional Cl- channel [4,5].
The GABA(A) receptor subunits are expressed in Wistar rat
kidney proximal convoluted and straight tubules [6]. The
GABA(A) receptor is rapidly activated by valproate in the
brain [7]. Cl- channels play a critical role in the function-
ing of the nervous system by asserting control over voltage
potentials across the plasma membrane [8]. There are gen-
der-related differences in Cl-  transport across the cell
membrane, intracellular Cl- level and the sensitivity of Cl-
transport to vasopressin in smooth muscle cells of rats [9].
Intracellular Cl- level and Cl- transport differences could
be important in the regulation of cellular processes and
could help to explain certain functional differences of
cells [9,10]. Cl- is an important factor of intracellular pH
[11], which is involved in the complex of cell function reg-
ulation.
Investigations show that K+-Cl- cotransport takes part in
the regulation of signaling pathways involved in several
tissue and cell types from different species [12]. In mode-
ling Cl- transport in the rat proximal tubule, Weinstein has
found that Cl- ions efflux from the cell predominantly via
the K+-Cl- cotransport mechanism [13]. The intracellular
Cl-  level is dependent upon the K+-Cl-co-transporter
(KCC) that determines whether neurons respond to GABA
by depolarization or hyperpolarization. However, the role
of KCC-dependent chloride homeostasis in the regulation
of spontaneous activity of neuronal circuits via GABA(A)
receptor is still unknown. Findings suggest that KCC-
dependent chloride homeostasis is mainly involved in
GABA(A) receptor-mediated synaptic inhibition [14].
There are no investigational data on the interaction
between KCC and GABA receptors, K+ homeostasis or
NaVPA effects on K+ and Cl- transport in the kidney.
The study provides data to show that NaVPA in rats, along
with the known diuretic and chloriduretic effects, causes
also a kaliuretic effect that has not yet been investigated.
For measurement of K+ in urine, the same animals and
samples as in our earlier publication were used (Pharma-
cology 2005 Nov, 75:111–115).
Methods
Twenty-six Wistar rats (13 NaVPA-males and 13 NaVPA-
females) were examined after a single intragastric dose of
300 mg/kg sodium valproate (Convulex, 300 mg/ml,
drops (water solution, pH 9.0), Gerot Pharmazeutika
Wien, Austria). In addition, 28 Wistar intact rats (14 males
and 14 females) were examined as a control group.
NaVPA dosage was chosen in accordance with data of pre-
clinical pharmacodynamic studies of NaVPA [15]. The
study was approved by the Lithuanian Committee for Ani-
mals Care and Use (No. 0019; 2005). The mean age of
control rats was 91 ± 9 days for males and 90 ± 8 days for
females, and the mean age of NaVPA-rats was 97 ± 10 days
for males and 95 ± 9 days for females. The mean weight of
male rats was 283 ± 30 g in control group and 298 ± 23 g
in NaVPA-rats. The mean weight of female rats was 236 ±
18 g in control and 240 ± 16 g in NaVPA-rats. The weight
was significantly higher in male than in female rats in
both groups (p < 0.05).
The animals were housed in standard colony cages with
free access to food (chow pellets) and tap water. The room
temperature was 21 ± 1°C. The rats were on a natural
light-dark cycle. All experiments were performed accord-
ing to the institutional guidelines for animal care in order
to avoid any unnecessary distress to the animals and to
reduce the number of animals used. The animals were
housed in described conditions and acclimated for at least
5 days before experiments. 24-h urine was collected keep-
ing a rat alone in a special cage (diuresis cage for rats
3700D000/3701D000, Tecniplast, Italy) for 24 h (from
9:00 a.m. till 9:00 a.m. of the next day) with free access to
tap water, without food, in the same temperature and
light conditions. 24-h urine was collected after a single
dose administration.
24-h urinary K+, Cl- levels were analyzed with an EML-105
electrolyte analyzer (Radiometer, Denmark). Urinary pH
levels were measured with a pH/mV/ion meter (ION
Meter pH 340/ION, Germany).
We calculated the 24-h excretion of K+, Cl-, creatinine, K+/
creatinine, Cl-/creatinine ratio, as well as 24-h diuresis
and 24-h urinary K+, Cl- excretion per 100 g of body
weight. Data were expressed as mean ± SD values from nBMC Pharmacology 2007, 7:9 http://www.biomedcentral.com/1471-2210/7/9
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animals. Comparisons between the groups were carried
out using Student' s t test. A value of p < 0.05 was consid-
ered significant. Correlations between two variables were
investigated by the method of linear correlation analysis.
The Pearson correlation coefficient r, which represents the
linear relationship between two variables, was applied; a
value of p < 0.05 was considered significant. STATISTICA
for Windows software (StatSoft, USA, 1995) was used to
perform the analysis of our data.
Results
Diuresis in control and NaVPA-rats
24-h diuresis in control rats showed no statistically signif-
icant gender-related differences (p > 0.05). 24-h diuresis
per 100 g of body weight in control female rats (3.90 ±
1.10 ml/100 g) was significantly higher (p < 0.02) than in
control male rats (2.89 ± 0.91 ml/100 g). After a single
intragastric administration of 300 mg/kg NaVPA, 24-h
diuresis was significantly (p < 0.05) higher in both gen-
ders as compared to control groups, without statistically
significant gender-related differences (Table 1). 24-h diu-
resis per 100 g of body weight in NaVPA-females (5.04 ±
1.66 ml/100 g) and NaVPA-males (5.38 ± 2.41 ml/100 g)
was significantly higher (p < 0.05) than in control female
and male rat groups (3.90 ± 1.10 ml/100 g, 2.89 ± 0.91
ml/100 g, respectively), with no statistically significant
gender-related differences.
No statistically significant correlation between 24-h diure-
sis and 24-h urinary K+ excretion or between 24-h diuresis
and 24-h urinary Cl- excretion was found in male and
female control rats (p > 0.05). Statistically significant cor-
relations between 24-h diuresis and 24-h K+ excretion (r =
0.64; p < 0.05) were found in NaVPA-males. There were
no statistically significant correlations between diuresis
and 24-h urinary K+ excretion in NaVPA-females (p > 0.05,
Figure 1). In NaVPA-male rats, the negative correlation
between Cl- excretion and 24-h diuresis (r = -0.56) and
between Cl- excretion and urine pH (r = -0.73) was signif-
icant (r = -0.73; p < 0.05), and no such correlations were
found for NaVPA-female rats (r = 0.18 and r = 0.02; p >
0.05, Figure 2, 3).
K+ excretion in control and NaVPA-rats
No statistically significant gender-related differences in
24-h urine K+ excretion and in the K+/creatinine ratio were
determined in control rats (p > 0.05). 24-h urinary K+
excretion per 100 g of body weight was significantly
higher in control females than in control males (p = 0.04;
Table 1). 24-h K+ excretion in NaVPA-male rats was signif-
icantly higher than in control male (p = 0.003) and
NaVPA-female rats (p < 0.001). 24-h K+  excretion in
NaVPA-female rats did not show statistically significant
difference versus female controls (p > 0.05). 24-h urinary
K+ excretion per 100 g of body weight in NaVPA-male rats
was significantly higher than in control males (p = 0.025;
Table 1). No gender-related differences in this index were
found in NaVPA-rats. This index in NaVPA-female rats did
not show any statistically significant difference as com-
pared with female controls (p > 0.05).
The K+/Cl- ratio (Table 2) in NaVPA-males and NaVPA-
females was significantly lower as compared to control
males (p < 0.0005) and control females (p < 0.0005),
without any statistically significant gender-related differ-
ences.
Cl- excretion in control and NaVPA-rats
No significant gender differences of 24-h urine, Cl- excre-
tion and Cl- excretion per 100 g of body weight and Cl-/
creatinine ratio were determined in control rats, either (p
> 0.05; Table 2).
Compared to control, 24-h urinary Cl- levels were signifi-
cantly (p < 0.05) higher in both genders of experimental
animals. 24-h urinary Cl- excretion, 24-h urinary Cl- excre-
tion per 100 g of body weight and the Cl-/creatinine ratio
in both sexes of NaVPA-rats were significantly higher than
in gender-matched controls (p < 0.001). Chloride excre-
tion (24-h urinary Cl- excretion, 24-h urinary Cl- excretion
per 100 g of body weight and the Cl-/creatinine ratio) was
Table 1: Diuresis and 24-h urinary K+ excretion in male and female control and NaVPA-rat groups (mean ± SD)
Rat groups n 24-h diuresis (ml) 24-h K+ level (mmol/l) 24-h K+ excretion (mmol) 24-h K+ excretion per 100 g 
body weight (mmol)
K+/creatinine ratio
Control rats
females 14 9.1 ± 2.3 116 ± 27 1.01 ± 0.17 0.43 ± 0.06* 13.9 ± 3.38
males 14 8.0 ± 2.1 135 ± 29 1.04 ± 0.18 0.37 ± 0.08* 12.7 ± 7.9
NaVPA-rats
females 13 12.1 ± 4.1• 84 ± 28• 0.93 ± 0.14* 0.39 ± 0.06 11.8 ± 2.34
males 13 16.0 ± 7.2• 93 ± 30• 1.32 ± 0.26• * 0.44 ± 0.08• 12.4 ± 2.88
• – Statistically significant difference as compared to control group (p < 0.05).
* – Statistically significant difference versus the other gender (p < 0.05).BMC Pharmacology 2007, 7:9 http://www.biomedcentral.com/1471-2210/7/9
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found significantly higher in NaVPA-male than in NaVPA-
female rats (p < 0.05; Table 2). 24-h creatinine excretion
in NaVPA-male rats (0.110 ± 0.025 mmol) was signifi-
cantly higher than in NaVPA-female rats (0.082 ± 0.017
mmol; p < 0.005). No gender-related difference in 24-h
creatinine excretion between control male and female rats
was determined (p > 0.05).
The 24-h urine pH showed no statistically significant dif-
ference between control females (6.57 ± 0.2) and control
males (6.53 ± 0.2; p > 0.05). The 24-h urine pH in NaVPA-
males (6.42 ± 0.3) and NaVPA-females (6.43 ± 0.3)
showed no statistically significant differences from con-
trols and between the genders (p > 0.05). In NaVPA-rats,
only the correlation between Cl- excretion and 24-h urine
pH was significant in NaVPA-males (r = -0.73; p < 0.05,
Figure 3). The correlation coefficient of 24-h urinary Cl-
excretion and urine pH statistically significantly differed
(p < 0.02) between control males (r = 0.03) and NaVPA-
males (r = -0.73), also between NaVPA-females and
NaVPA-males (r = 0.02, r = -0.73, p < 0.05), without any
statistically significant differences in control females and
males (p > 0.05).
The correlation between 24-h urinary K+ and Cl- excretion
and between respective electrolyte and 24-h urine pH in
control male and female rats was not statistically signifi-
cant (p > 0.05). The correlation coefficient of 24-h urinary
K+ excretion and 24-h urinary Cl- excretion statistically sig-
nificantly differed (p = 0.03) only between control males
(r = -0.28) and control females (r = 0.49).
Discussion
Cl- and K+ fluxes play a crucial role in synaptic inhibition,
cell pH regulation, as well as in cell volume control and
tissue susceptibility to seizures [16,17]. A recent study
showed that NaVPA, alongside the diuretic effect,
enhances sodium and Cl- excretion with urine [3]. Acute
and subacute administration of valproic acid has been
shown to exert a moderate diuretic effect on rats [9,18,19].
The study data showed that intragastric 300 mg/kg NaVPA
significantly increased 24-h K+ excretion in the urine of
NaVPA-male rats. 24-h K+ excretion in NaVPA-male rats
was significantly higher than in control males and
NaVPA-female rats. 24-h urinary K+ excretion per 100 g of
body weight in NaVPA-male rats was significantly higher
than in control male rats.
Correlation between urine pH and Cl- excretion in NaVPA  male and female rats Figure 3
Correlation between urine pH and Cl- excretion in NaVPA 
male and female rats. * – Statistically significant correlation.
Correlation between 24-h diuresis and K+ excretion in  NaVPA male and female rats Figure 1
Correlation between 24-h diuresis and K+ excretion in 
NaVPA male and female rats. * – Statistically significant cor-
relation.
Correlation between 24-h diuresis and Cl- excretion in  NaVPA male and female rats Figure 2
Correlation between 24-h diuresis and Cl- excretion in 
NaVPA male and female rats. * – Statistically significant cor-
relation.BMC Pharmacology 2007, 7:9 http://www.biomedcentral.com/1471-2210/7/9
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The enhanced excretion of K+ and Cl- with urine and the
related gender differences of NaVPA effect could be
important for elucidating the pathophysiological phe-
nomena related to NaVPA pharmacology. GABA func-
tions appear to be triggered by GABA binding to its
ionotropic receptors, which are ligand-gated Cl- channels
[4,5]. The Cl- channel of the GABA(A) receptor is activated
by valproic acid in brain cells [7]. GABA was also found to
activate K+ conductance in the central nervous system
[20], it is involved in a wide variety of physiological func-
tions in tissues and organs outside the brain [12,21]. Acti-
vation of the GABA(A) receptor leads to a stimulation of
Na+-K+-2Cl- cotransporter in brain cells, and this results in
a loss of intracellular Cl- [22] or in an upregulation of KCC
which is important in maintaining the low intracellular
Cl- level [23].
Studies demonstrating K+-Cl- cotransport in rabbit proxi-
mal tubules have shown a coupled K+-Cl- movement from
the cell to peritubular fluid [24]. In addition, several
modes of coupled K+ and Cl- movement have been shown
in K+ excretion by renal tubules: directly coupled K+-Cl-
cotransport, parallel K+ and Cl- conductance, parallel K+/
H+ and Cl-/HCO3- exchangers and Na+-K+-2Cl- cotrans-
port [25]. In modeling Cl- transport in the rat proximal
tubule, Weinstein found that Cl- effluxes from the cell pre-
dominantly via K+-Cl- cotransport [13].
The presence and physiological significance of GABA or
GABA(A) receptors in nonneural tissue is less clear [26].
The effect of pharmacological manipulation of GABAergic
transmission on KCC activity in the kidney remains to be
clarified. GABA immunoreactivity in the rat kidney was
predominantly confined to renal tubules, including the
ascending parts of the distal tubules, and the loop of
Henle, the collecting tubules and ducts, and the connec-
tive parts of the convoluted tubules. The high K+ concen-
tration evoked an efflux of endogenous GABA from rat
kidney slices. GABA released from renal tubular epithe-
lium and transported with urine might be involved in the
modulation of K+ transport in the urinary tract cells [27].
However, our findings allow to hypothesize that GABA(A)
subunits may play a role in basolateral membrane Cl-
transport. These findings support the suggestion of other
investigators, that subunits of the ligand-gated Cl- channel
superfamily may be involved in renal Cl- excretion [6].
NaVPA exerts a gender-related effect on urinary Cl- excre-
tion: 24-h urinary Cl- excretion was significantly higher in
rats of both sexes, but Cl-  excretion was significantly
higher in male than in female rats. In NaVPA-male rats,
the negative correlation between Cl- excretion and 24-diu-
resis and between Cl- excretion and urine pH was signifi-
cant, but such correlations were not characteristic of
control male or NaVPA-female rats. The K+/Cl- ratio in
NaVPA-males and NaVPA-females was significantly lower
as compared to control males and control females, with-
out gender-related differences. There are no data that
could contribute to elucidating the mechanisms of
NaVPA-induced enhanced urinary Cl-  excretion. It is
known that the alkaline extracellular pH increases the
GABA(A) channel opening frequency and decreases the
duration of the long-closed state in rat hypothalamus
[28]. There are no data that NaVPA influences tubular
intracellular and extracellular pH. Gender-related differ-
ences in intracellular Cl- concentration and Cl- transport
in smooth muscle cells of male and female rats have been
reported [9]. Sexual dimorphism in the expression of
KCC, GABA receptors and in GABA release in the nervous
system of rats is a known fact [29-35].
Tissue distribution studies with radiolabeled NaVPA in
rodents have shown that NaVPA distributed mainly in the
extracellular space; high levels of radiolabeled NaVPA
were found in the liver and kidney [36]. We failed to find
data on gender-related differences of NaVPA pharmacoki-
netics, pharmacodynamics, or gender differences of
NaVPA metabolism in rats. The NaVPA-induced K+ and
Cl- excretion enhancement may be related to the upregu-
lated renal hemodynamics, as the NaVPA doses applied
are known to reduce arterial blood pressure in rats: NaVPA
provoked a prolonged cardiovascular depression which
was very similar to that observed with high i.v. doses of
GABA [18,37]. The mechanism of the cardio depressive
Table 2: 24-h urinary chloride (Cl-) excretion data and K+/Cl- ratio in male and female control and NaVPA-rat groups (mean ± SD)
Rat groups n 24-h Cl- level (mmol/l) 24-h Cl- excretion (mmol/24 h) 24-h Cl- excretion per 100 g 
body weight (mmol/100 g)
Cl-/creatinine ratio K+/Cl- ratio
Control rats
females 14 104 ± 51 0.886 ± 0.40 0.371 ± 0.15 12.6 ± 6.9 1.30 ± 0.44
males 14 168 ± 128 1.164 ± 0.70 0.420 ± 0.26 14.2 ± 8.8 1.15 ± 0.54
NaVPA-rats
females 13 180 ± 60• 1.997 ± 0.52• * 0.833 ± 0.22• * 24.6 ± 4.7• * 0.49 ± 0.12•
males 13 275 ± 184• 3.396 ± 1.21• * 1.208 ± 0.53• * 34.6 ± 16.5• * 0.45 ± 0.22•
• – Statistically significant difference, as compared to control group (p < 0.05).
* – Statistically significant difference versus the other gender (p < 0.05).BMC Pharmacology 2007, 7:9 http://www.biomedcentral.com/1471-2210/7/9
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effect of NaVPA is not clear; it seems not to involve inter-
ference with peripheral vascular noradrenergic activity or
arterial baroreflex control [38]. Furthermore, Cl- is an
important factor of renal vascular tone or renal hemody-
namics regulation. Renal arterial infusion of Cl- acts as a
direct vasoconstrictor [39]; retrograde injection of Cl--
containing solution into the distal tubule elicits a decrease
in a single nephron glomerular filtration rate, whereas
injection of sodium ion containing solution without Cl-
does not [40]. In oncotically perfused rat kidneys, in the
presence of either high or low Cl- with sodium kept con-
stant, low Cl- resulted in a higher glomerular filtration rate
than with high chloride [41]. It is not likely that the
NaVPA-induced gender-related K+  and Cl-  excretion is
linked to Na+-K+-2Cl- cotransporter inhibition, because
the Na+-K+-2Cl- cotransporter inhibitor furosemide exerts
an opposite gender-related chloriduretic effect in rats [42].
Conclusion
NaVPA, alongside the diuretic effect, enhances K+ and Cl-
excretion with urine in rats of both genders. The mecha-
nism of this different gender-dependent effect is not yet
clear. The experimental observations reported above may
have potentially important pharmacological implica-
tions. Elucidation of NaVPA-induced mechanisms of
enhanced K+ and Cl- excretion could be of value while
explaining the pharmacological basis of NaVPA action.
Thus, further studies of the mechanisms of NaVPA effects
on K+ and Cl- transport in cells could be important.
Abbreviations
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K+ = potassium
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